Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription

Articles published in Int J Hematol

Retrieve available abstracts of 50 articles:
HTML format

Single Articles

    August 2022
  1. CAMASCHELLA C, Pagani A, Silvestri L, Nai A, et al
    The mutual crosstalk between iron and erythropoiesis.
    Int J Hematol. 2022;116:182-191.
    PubMed     Abstract available

  2. MIYAZAKI Y, Kiguchi T, Sato S, Usuki K, et al
    Prospective comparison of 5- and 7-day administration of azacitidine for myelodysplastic syndromes: a JALSG MDS212 trial.
    Int J Hematol. 2022;116:228-238.
    PubMed     Abstract available

    July 2022
  3. KAWABATA H, Tamura T, Tamai S, Takahashi T, et al
    Intravenous ferric derisomaltose for iron-deficiency anemia associated with gastrointestinal diseases: a single-arm, randomized, uncontrolled, open-label study.
    Int J Hematol. 2022 Jul 22. pii: 10.1007/s12185-022-03420.
    PubMed     Abstract available

  4. KAWABATA H, Tamura T, Tamai S, Fujibayashi A, et al
    Intravenous ferric derisomaltose versus saccharated ferric oxide for iron deficiency anemia associated with menorrhagia: a randomized, open-label, active-controlled, noninferiority study.
    Int J Hematol. 2022 Jul 6. pii: 10.1007/s12185-022-03401.
    PubMed     Abstract available

  5. KAMURA Y, Sakamoto T, Yokoyama Y, Nishikii H, et al
    Hemolysis induced by SARS-CoV-2 mRNA vaccination in patients with paroxysmal nocturnal hemoglobinuria.
    Int J Hematol. 2022;116:55-59.
    PubMed     Abstract available

  6. SAKAGUCHI H, Yoshida N
    Recent advances in hematopoietic cell transplantation for inherited bone marrow failure syndromes.
    Int J Hematol. 2022;116:16-27.
    PubMed     Abstract available

    June 2022
  7. MURAKAMI D, Matsuda K, Honda A, Masamoto Y, et al
    Severe infections and renal dysfunction during immunosuppressive therapy with cyclosporine A for aplastic anemia.
    Int J Hematol. 2022 Jun 24. pii: 10.1007/s12185-022-03399.
    PubMed     Abstract available

  8. KAWAKAMI F, Kawakami T, Yamane T, Maruyama M, et al
    T cell clonal expansion and STAT3 mutations: a characteristic feature of acquired chronic T cell-mediated pure red cell aplasia.
    Int J Hematol. 2022;115:816-825.
    PubMed     Abstract available

    April 2022
  9. JITPIRASAKUN S, Pooliam J, Sriwichakorn C, Sanpakit K, et al
    Differences in longitudinal growth patterns of children and adolescents with transfusion-dependent hemoglobin E/beta-thalassemia and those achieving successful hematopoietic stem-cell transplantation.
    Int J Hematol. 2022;115:575-584.
    PubMed     Abstract available

  10. IKEZOE T, Noji H, Ueda Y, Kanda Y, et al
    Long-term follow-up of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab: post-marketing surveillance in Japan.
    Int J Hematol. 2022;115:470-480.
    PubMed     Abstract available

  11. HAYAMA K, Abe Y, Kamata H, Okina S, et al
    Bone marrow ring sideroblasts in hematological diseases: an analysis of consecutive 1300 samples in a single institution.
    Int J Hematol. 2022;115:508-514.
    PubMed     Abstract available

    March 2022
  12. YOUSSRY I, ElGhamrawy M, Seif H, Balsamo L, et al
    Prevalence and risk factors of cognitive impairment in children with sickle cell disease in Egypt.
    Int J Hematol. 2022;115:399-405.
    PubMed     Abstract available

  13. HIDAKA D, Ogasawara R, Sugimura S, Fujii F, et al
    New-onset Evans syndrome associated with systemic lupus erythematosus after BNT162b2 mRNA COVID-19 vaccination.
    Int J Hematol. 2022;115:424-427.
    PubMed     Abstract available

    February 2022
  14. SAMPAGAR A, Gosavi M, Kedar P, Patel T, et al
    Clinical, laboratory, and mutational profile of children with glucose phosphate isomerase deficiency: a single centre report.
    Int J Hematol. 2022;115:255-262.
    PubMed     Abstract available

    January 2022
  15. ELENGA N, Vantilcke V, Martin E, Cuadro E, et al
    Red blood cell exchange in children with sickle cell disease.
    Int J Hematol. 2022;115:107-113.
    PubMed     Abstract available

    September 2021
  16. WANG Z, Sun W, Chen H, Zhang Y, et al
    Prevalence and molecular spectrum of alpha- and beta-globin gene mutations in Hainan, China.
    Int J Hematol. 2021;114:307-318.
    PubMed     Abstract available

    July 2021
  17. GASIOR KABAT M, Bueno D, Sisinni L, De Paz R, et al
    Selective T-cell depletion targeting CD45RA as a novel approach for HLA-mismatched hematopoietic stem cell transplantation in pediatric nonmalignant hematological diseases.
    Int J Hematol. 2021;114:116-123.
    PubMed     Abstract available

  18. LIU X, Cheng L, He Y, Zhang R, et al
    Eltrombopag restores erythropoiesis in refractory adult acquired pure red cell aplasia.
    Int J Hematol. 2021;114:124-128.
    PubMed     Abstract available

    Regarding chronic graft-versus-host disease in children and adolescents with thalassemia after hematopoietic stem cell transplantation.
    Int J Hematol. 2021;114:147-148.

    June 2021
  20. YOSHINARI H, Kawahara Y, Niijima H, Oh Y, et al
    Rapid blood cell recovery with immunosuppressive therapy combined with romiplostim in a patient with very severe hepatitis-associated aplastic anemia who underwent liver transplantation.
    Int J Hematol. 2021 Jun 10. pii: 10.1007/s12185-021-03165.
    PubMed     Abstract available

    May 2021
  21. MAHE K, Couturaud F, Kerspern H, Chauveau A, et al
    Evaluation of beta-2 microglobulin, erythropoietin and tobacco use in polycythemic cases.
    Int J Hematol. 2021 May 22. pii: 10.1007/s12185-021-03164.
    PubMed     Abstract available

    April 2021
  22. CHEN S, Guo Z, Ye Y, Yang S, et al
    Compound heterozygosity for two novel mutations of the SEC23B gene in congenital dyserythropoietic anemia type II.
    Int J Hematol. 2021 Apr 29. pii: 10.1007/s12185-021-03155.
    PubMed     Abstract available

  23. NARUKAWA K, Masuda A, Takahashi T
    Marked erythropoietin-induced dysplastic erythropoiesis in a patient with myelodysplastic syndrome.
    Int J Hematol. 2021 Apr 17. pii: 10.1007/s12185-021-03147.

  24. LERTKOVIT O, Anurathapan U, Hongeng S, Thokanit NS, et al
    Chronic graft-versus-host disease in children and adolescents with thalassemia after hematopoietic stem cell transplantation.
    Int J Hematol. 2021;113:556-565.
    PubMed     Abstract available

    March 2021
  25. KOMATSU N, Arita K, Mitsui H, Nemoto T, et al
    Efficacy and safety of ferric citrate hydrate compared with sodium ferrous citrate in Japanese patients with iron deficiency anemia: a randomized, double-blind, phase 3 non-inferiority study.
    Int J Hematol. 2021 Mar 15. pii: 10.1007/s12185-021-03123.
    PubMed     Abstract available

  26. OTSUKA H, Endo Y, Ohtsu H, Inoue S, et al
    Histidine decarboxylase deficiency inhibits NBP-induced extramedullary hematopoiesis by modifying bone marrow and spleen microenvironments.
    Int J Hematol. 2021;113:348-361.
    PubMed     Abstract available

    February 2021
  27. VIVES-CORRONS JL, Krishnevskaya E, Rodriguez IH, Ancochea A, et al
    Characterization of hereditary red blood cell membranopathies using combined targeted next-generation sequencing and osmotic gradient ektacytometry.
    Int J Hematol. 2021;113:163-174.
    PubMed     Abstract available

  28. PINCZES LI, Szabo R, Miltenyi Z, Illes A, et al
    The impact of autoimmune cytopenias on the clinical course and survival of Hodgkin lymphoma.
    Int J Hematol. 2021;113:175-182.
    PubMed     Abstract available

    January 2021
  29. ROSTAMI T, Monzavi SM, Poustchi H, Khoshdel AR, et al
    Analysis of determinant factors of liver fibrosis progression in ex-thalassemic patients.
    Int J Hematol. 2021;113:145-157.
    PubMed     Abstract available

  30. NAKAMURA Y, Takenaka K, Yamazaki H, Onishi Y, et al
    Outcome of allogeneic hematopoietic stem cell transplantation in adult patients with paroxysmal nocturnal hemoglobinuria.
    Int J Hematol. 2021;113:122-127.
    PubMed     Abstract available

    December 2020
  31. SUN Y, Liu C, Jiao T, Xie N, et al
    Decreased LAG3 expression on T effector cells and regulatory T cells in SAA.
    Int J Hematol. 2020;112:757-763.
    PubMed     Abstract available

    October 2020
  32. NAKAYA A, Kohara T, Shibayama H, Onda Y, et al
    Retrospective multi-center study of Adolescent and Young Adult (AYA) Multiple Myeloma in Kansai Myeloma Forum registry.
    Int J Hematol. 2020;112:435-438.
    PubMed     Abstract available

  33. ISHIYAMA K, Nakao S, Usuki K, Yonemura Y, et al
    Results from multinational phase 3 studies of ravulizumab (ALXN1210) versus eculizumab in adults with paroxysmal nocturnal hemoglobinuria: subgroup analysis of Japanese patients.
    Int J Hematol. 2020;112:466-476.
    PubMed     Abstract available

    September 2020
  34. YABE M, Morio T, Tabuchi K, Tomizawa D, et al
    Long-term outcome in patients with Fanconi anemia who received hematopoietic stem cell transplantation: a retrospective nationwide analysis.
    Int J Hematol. 2020 Sep 19. pii: 10.1007/s12185-020-02991.
    PubMed     Abstract available

  35. ISE M, Iizuka H, Kamoda Y, Hirao M, et al
    Romiplostim is effective for eltrombopag-refractory aplastic anemia: results of a retrospective study.
    Int J Hematol. 2020 Sep 2. pii: 10.1007/s12185-020-02971.
    PubMed     Abstract available

  36. KAMESAKI T, Nishimura JI, Wada H, Yu E, et al
    Demographic characteristics, thromboembolism risk, and treatment patterns for patients with cold agglutinin disease in Japan.
    Int J Hematol. 2020;112:307-315.
    PubMed     Abstract available

    August 2020
  37. AKRAM T, Fatima A, Klar J, Hoeber J, et al
    Aberrant splicing due to a novel RPS7 variant causes Diamond-Blackfan Anemia associated with spontaneous remission and meningocele.
    Int J Hematol. 2020 Aug 9. pii: 10.1007/s12185-020-02950.
    PubMed     Abstract available

  38. YE L, Zhang F, Kojima S
    Current insights into the treatments of severe aplastic anemia in China.
    Int J Hematol. 2020 Aug 3. pii: 10.1007/s12185-020-02955.
    PubMed     Abstract available

    June 2020
  39. HONG J, Ni J, Ruan M, Yang M, et al
    LMP1-specific cytotoxic T cells for the treatment of EBV-related post-transplantation lymphoproliferative disorders.
    Int J Hematol. 2020;111:851-857.
    PubMed     Abstract available

    May 2020
  40. KAGEYAMA Y, Katayama N
    Ontogeny of human B1 cells.
    Int J Hematol. 2020;111:628-633.
    PubMed     Abstract available

  41. SAKURAI M, Takemoto H, Mori T, Okamoto S, et al
    In vivo expansion of functional human hematopoietic stem progenitor cells by butyzamide.
    Int J Hematol. 2020;111:739-741.

    April 2020
  42. EDAHIRO Y, Yasuda H, Ando K, Komatsu N, et al
    Self-limiting pregnancy-associated pure red cell aplasia developing in two consecutive pregnancies: case report and literature review.
    Int J Hematol. 2020;111:579-584.
    PubMed     Abstract available

    March 2020
  43. CHE YAACOB NS, Islam MA, Alsaleh H, Ibrahim IK, et al
    Alpha-hemoglobin-stabilizing protein (AHSP): a modulatory factor in beta-thalassemia.
    Int J Hematol. 2020;111:352-359.
    PubMed     Abstract available

    February 2020
  44. NOPPARATANA C, Nopparatana C, Saechan V, Karnchanaopas S, et al
    Prenatal diagnosis of alpha- and beta-thalassemias in southern Thailand.
    Int J Hematol. 2020;111:284-292.
    PubMed     Abstract available

    January 2020
  45. KITAO A, Kawamoto S, Kurata K, Hayakawa I, et al
    Band 3 ectopic expression in colorectal cancer induces an increase in erythrocyte membrane-bound IgG and may cause immune-related anemia.
    Int J Hematol. 2020 Jan 30. pii: 10.1007/s12185-020-02831.
    PubMed     Abstract available

  46. JIANG J, Cai Y, Wan L, Yang J, et al
    Cord blood infusion-accelerated hematopoietic recovery after combined immunosuppressive therapy with fludarabine and rabbit ATG in severe aplastic anemia.
    Int J Hematol. 2020 Jan 3. pii: 10.1007/s12185-019-02807.
    PubMed     Abstract available

    November 2019
  47. YASUDA H, Tsutsui M, Ando J, Inano T, et al
    Vitamin B6 deficiency is prevalent in primary and secondary myelofibrosis patients.
    Int J Hematol. 2019;110:543-549.
    PubMed     Abstract available

    October 2019
  48. SAKURAI M, Jang JH, Chou WC, Kim JS, et al
    Comparative study on baseline clinical characteristics of Asian versus non-Asian patients with paroxysmal nocturnal hemoglobinuria.
    Int J Hematol. 2019;110:411-418.
    PubMed     Abstract available

  49. MANKHEMTHONG K, Phusua A, Suanta S, Srisittipoj P, et al
    Molecular characteristics of thalassemia and hemoglobin variants in prenatal diagnosis program in northern Thailand.
    Int J Hematol. 2019;110:474-481.
    PubMed     Abstract available

    August 2019
  50. JANG W, Kim J, Chae H, Kim M, et al
    Hereditary spherocytosis caused by copy number variation in SPTB gene identified through targeted next-generation sequencing.
    Int J Hematol. 2019;110:250-254.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Anemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.